Research Overview
Research on 7-Keto DHEA (7-oxo-DHEA) has most commonly focused on its potential metabolic effects in the context of overweight/obesity and dieting, particularly whether it can mitigate the reduction in resting metabolic rate (RMR) that often accompanies calorie restriction. The most studied outcomes in the available abstract are short-term changes in RMR measured by indirect calorimetry, along with basic tolerability/adverse-event monitoring. The cited randomized, double-blind, placebo-controlled, crossover trial in overweight adults on a calorie-restricted diet found that 7-Keto (and a multi-ingredient formulation containing 7-Keto plus micronutrients and green tea extract) increased RMR relative to placebo over 7-day treatment periods, whereas placebo was associated with an RMR decrease. Reported adverse events did not differ meaningfully between conditions, and no serious adverse events were observed in this short-duration study.
The strongest evidence supported by this abstract is that 7-Keto can produce a modest, short-term increase in RMR (or prevent the typical diet-associated decline) under controlled conditions, with short-term tolerability appearing acceptable in the studied population. However, the evidence base reflected here is limited in duration and scope: the intervention periods were brief (7 days), the sample size was moderate (40 completers), and one arm involved a combination product (HUM5007), which complicates attribution of effects to 7-Keto alone for that condition. Importantly, RMR is a surrogate endpoint; the abstract does not establish whether these changes translate into clinically meaningful outcomes such as sustained fat loss, improved body composition, or long-term weight maintenance.
Key areas needing more research include longer-term randomized trials evaluating clinically relevant endpoints (body weight, fat mass, waist circumference, and weight regain after dieting), dose–response relationships, and durability of any metabolic effects beyond one week. Additional work is also needed to clarify mechanisms (e.g., thermogenesis, substrate oxidation), to separate the effects of 7-Keto from co-ingredients in combination formulations, and to better characterize safety with longer exposure and in diverse populations (e.g., older adults, people with cardiometabolic disease, and those taking common medications). Replication by independent groups and standardized reporting of adverse events and metabolic measurements would strengthen confidence in the findings.
1. What conditions has 7-Keto DHEA been studied for?
Overweight/obesity in the context of dieting (calorie restriction): The provided abstract studied overweight adults (mean BMI ~32 kg/m2) maintained on a calorie-restricted diet, focusing on whether 7-Keto could affect resting metabolic rate (RMR) during dieting.
Diet-associated metabolic slowdown: Specifically, it was tested for its ability to counter the typical decrease in RMR that occurs during calorie restriction.
2. Does it work in treating those conditions? Summarize the evidence.
Evidence from the abstract suggests a short-term increase (or preservation) of RMR during dieting.
Study design: Randomized, double-blind, placebo-controlled, crossover trial with three 7-day treatment periods (7-Keto alone, a multi-ingredient combination containing 7-Keto [HUM5007], and placebo) separated by 7-day washouts; RMR measured by indirect calorimetry.
Primary finding (RMR): During placebo, RMR decreased by 3.9% (~75 kcal/day). During 7-Keto, RMR increased by 1.4% (~21 kcal/day), and during HUM5007 it increased by 3.4% (~59 kcal/day). Both active treatments differed significantly from placebo (P = .001).
Interpretation: In this short trial, 7-Keto (and the combination product) reversed the decrease in RMR normally associated with dieting and increased RMR above baseline.
Limitations: The treatment periods were only 7 days each; the abstract does not report outcomes such as weight loss, fat loss, long-term maintenance, appetite, or cardiometabolic markers. Therefore, evidence supports an effect on RMR in the short term, but does not establish clinically meaningful long-term outcomes.
3. What health benefits does it have?
May help preserve or increase resting metabolic rate during calorie restriction: Compared with placebo (which showed a decline in RMR), 7-Keto increased RMR over 7 days in overweight adults on a calorie-restricted diet.
Potential support for energy expenditure in obesity: The authors suggest it “may benefit obese individuals with impaired energy expenditure,” based on the observed RMR changes.
Important caveat: The abstract supports a benefit on RMR only; it does not demonstrate downstream benefits such as improved body composition, metabolic health, or clinical outcomes.
4. Does it have any downsides or side effects?
Tolerability in the study: The abstract reports no significant differences in adverse events between treatment periods and states that 7-Keto and HUM5007 were generally well tolerated, with no serious adverse events reported.
Limitations of the safety evidence: Safety conclusions are constrained by the short duration (7-day exposure per condition) and modest sample size (40 completers). Rare side effects, longer-term risks, and effects in specific populations (e.g., pregnancy, endocrine disorders, adolescents) cannot be assessed from this abstract.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
The provided abstract does not report any pharmacogenomic analyses (no genotype-stratified outcomes, no gene–supplement interactions, and no mention of genetic variants affecting response or risk).
Evidence-based conclusion from the abstract: Unknown—there is no direct evidence here that any genetic variation makes 7-Keto DHEA more beneficial or more harmful.
Practical implication: At present (based on the supplied evidence), there is no basis to recommend 7-Keto DHEA differently according to genotype.
References
-
HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults
John L Zenk, Joy L Frestedt, Michael A Kuskowski (2007)
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!